Ambispective post-market data collection on visual symptoms, patient satisfaction and surgeon experience with the TECNIS PC IOL.

Inclusion Criteria:

• Patients who are bilaterally implanted with TECNIS PC IOL and are at least 45 days postoperative from their second eye surgery
• Clear intraocular media
• Signed informed consent and data protection documentation
• Availability, willingness, ability, and sufficient cognitive awareness to comply with examination procedures
• Ability to understand, read, and write English or the local language in which the informed consent and questionnaires are provided

Exclusion Criteria:

• Subjects with ongoing adverse events that might impact outcomes during the study
• Use of systemic or ocular medication that may affect vision
• Acute or chronic disease or condition, ocular trauma or surgery that may confound results
• Patients with amblyopia, strabismus, nystagmus
• Concurrent participation in another clinical trial

A pre-existing population of subjects bilaterally implanted with the PC IOL at approximately 20 sites in Europe and Asia Pacific. Bilateral pseudophakic subjects implanted with the TECNIS PC IOL will be enrolled.

Johnson & Johnson Medical Device Companies have an agreement with the Yale Open Data Access (YODA) to serve as the independent review panel for evaluation of requests for clinical study reports and participant level data from investigators and physicians for scientific research that will advance medical knowledge and public health. Requests for access to the study data can be submitted through the YODA Project site at http://yoda.yale.edu